Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-18-009051)

Filing Details

Accession Number:: 0001127602-18-009051
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-02-28 15:40:45
Reporting Period:: 2018-02-26

Accepted Time:: 2018-02-28 15:40:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1141722	C James Foster	251 Ballardvale Street Wilmington MA 01887	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-02-26	100	$108.56	306,914	No	4	S	Direct
Common Stock	Disposition	2018-02-26	300	$108.59	306,614	No	4	S	Direct
Common Stock	Disposition	2018-02-26	100	$108.60	306,514	No	4	S	Direct
Common Stock	Disposition	2018-02-26	100	$108.67	306,414	No	4	S	Direct
Common Stock	Disposition	2018-02-26	100	$108.69	306,314	No	4	S	Direct
Common Stock	Disposition	2018-02-26	100	$109.50	306,214	No	4	S	Direct
Common Stock	Disposition	2018-02-26	100	$109.51	306,114	No	4	S	Direct
Common Stock	Disposition	2018-02-27	2,174	$108.95	303,940	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,208	Indirect	2016 GRAT
Common Stock	29,954	Indirect	2017 GRAT
Common Stock	340	Indirect	By Trust
Common Stock	10,000	Indirect	Held By Spouse

Footnotes

This sale occurred pursuant to a 10b5-1 Trading Plan.